These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22330972)

  • 1. Diabetes: Glycemic and blood-pressure control--lower is not better.
    Ruilope LM
    Nat Rev Nephrol; 2012 Feb; 8(4):199-200. PubMed ID: 22330972
    [No Abstract]   [Full Text] [Related]  

  • 2. Vildagliptin in renal impairment.
    Dongre N; Kothny W
    J Nephrol; 2014 Jun; 27(3):349. PubMed ID: 24800907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertension in diabetes mellitus. Causes, follow-up and treatment].
    Klaus D
    Med Klin (Munich); 1994 Jun; 89(6):330-8. PubMed ID: 8072457
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic patients and kidney protection: an attainable target.
    Barit D; Cooper ME
    J Hypertens Suppl; 2008 Jun; 26(2):S3-7. PubMed ID: 18979716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Valsartan: arguments for the high dose concept].
    MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition.
    Veelken R; Delles C; Hilgers KF; Schmieder RE
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):672-8. PubMed ID: 11465652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
    Chalmers J; Joshi R; Kengne AP; MacMahon S
    J Hypertens Suppl; 2008 Jun; 26(2):S11-5. PubMed ID: 18979718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
    van Bommel EJM; Muskiet MHA; Tonneijck L; Kramer MHH; Nieuwdorp M; van Raalte DH
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):700-710. PubMed ID: 28254770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypertensive therapy in diabetes mellitus].
    Hess B
    Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and the diabetic hypertensive patient.
    Parving HH; Rossing P
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):47-52. PubMed ID: 8503435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy.
    Persson F; Lewis JB; Lewis EJ; Rossing P; Hollenberg NK; Parving HH
    Clin J Am Soc Nephrol; 2011 May; 6(5):1025-31. PubMed ID: 21350110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes: Renal benefits of lowering BP in the absence of hypertension.
    Suzuki H
    Nat Rev Nephrol; 2009 Jul; 5(7):370-1. PubMed ID: 19556992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current update in the management of diabetic nephropathy.
    Van Buren PN; Toto R
    Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk.
    Schernthaner G; Schernthaner GH
    J Nephrol; 2013; 26(6):975-85. PubMed ID: 23807645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
    de Zeeuw D
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.
    Sowers JR; Haffner S
    Hypertension; 2002 Dec; 40(6):781-8. PubMed ID: 12468556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Bothe D
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2390; author reply 2390-1. PubMed ID: 23132160
    [No Abstract]   [Full Text] [Related]  

  • 19. Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy.
    Epstein M
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):310-1. PubMed ID: 16932450
    [No Abstract]   [Full Text] [Related]  

  • 20. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
    Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.